Cited by 263Nanoparticle-Based Drug DeliveryNanoparticles: synthesis and applicationsGold and Silver Nanoparticles Synthesis and Applications

Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System

Open access
Barbero, Francesco, Russo, Lorenzo, Vitali, Michele, Piella, Jordi, Salvo, Ignacio, Borrajo, Mireya L., Busquets-Fité, Marti, Grandori, Rita +3 more·2017·Seminars in Immunology

Abstract

The interaction of inorganic nanoparticles and many biological fluids often withstands the formation of a Protein Corona enveloping the nanoparticle. This Protein Corona provides the biological identity to the nanoparticle that the immune system will detect. The formation of this Protein Corona depends not only on the composition of the nanoparticle, its size, shape, surface state and exposure time, but also on the type of media, nanoparticle to protein ratio and the presence of ions and other molecular species that interfere in the interaction between proteins and nanoparticles. This has important implications on immune safety, biocompatibility and the use of nanoparticles in medicine.

Integrity signals

Registry

Crossref · 10.1016/j.smim.2017.10.001

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Protein corona presents a major obstacle to bench-to-bedside translation of targeted drug delivery systems, severely affecting targeting yields and directing unfavorable biodistribution.

    “Protein corona presents a major obstacle to bench-to-bedside translation of targeted drug delivery systems, severely affecting targeting yields and directing unfavorable biodistribution.”

The citation lists haven’t been fetched yet

References 117 · Cited by 263

Authors
Barbero, F., Russo, L., Vitali, M., Piella, J., Salvo, I., Borrajo, M. L., Busquets-Fité, M., Grandori, R., Bastús, N. G., Casals, E., & Puntes, V.
Affiliations
  • Universitat Autònoma de Barcelona (ES)
  • Vall d'Hebron Institut de Recerca (ES)
  • University of Milano-Bicocca (IT)
  • Consejo Superior de Investigaciones Científicas (ES)
Venue
Seminars in Immunology
Publisher
Elsevier BV
Published
2017-12
Volume
34
Pages
52-60
ISSN
1044-5323 (ISSN-L)
OpenAlex
W2766753913
Cited by
263
References
117
Citations by year
2026: 16 · 2025: 20 · 2024: 19 · 2023: 42 · 2022: 41 · 2021: 55 · 2020: 43 · 2019: 22 · 2018: 5
FWCI
1.39
Type
journal article
Language
en
Open access
Locations
  • Seminars in Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
  • BOA (University of Milano-Bicocca) (submittedVersion, cc-by-nc-nd)
Funders
  • Spanish Monasterio de Ciencia e Innovación (MAT2015-70725-R)
  • Catalan Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) (2014-SGR-612)
  • Pandora European Training Network (GA-671881)
  • Spanish MINECO through the Severo Ochoa Centres of Excellence Programme (SEV-2013-0295)
  • MINECO through the Ramon y Cajal program (RYC-2012-10991)
  • Ministry of Health of the Government of Catalonia through PERIS (SLT002/16/00312)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
  • Physical Sciences › Materials Science › Electronic, Optical and Magnetic Materials › Gold and Silver Nanoparticles Synthesis and Applications
Keywords
protein corona, nanoparticle-protein interactions, immune system, nanoparticle biocompatibility, nanoparticle toxicity, nanoparticle size and shape, surface functionalization, ionic strength effects, biological fluids
MeSH terms
Protein Corona, Animals, Biocompatible Materials, Humans, Immune System, Particle Size, Nanomedicine, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review